Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia

Cancer Genetics

Volumn 206, Issue 3, 2013, Pages 97-101

  Balatzenko, Gueorgui ^a   Guenova, Margarita ^a   Kalinova, Ivelina ^b   Belcheva, Milena ^b   Hristozova, Hristina ^b   Kaleva, Valeria ^b  

^a National Specialized Hospital for Active Treatment of Hematological Diseases   (Bulgaria)

^b UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

Author keywords

Acute lymphoblastic leukemia; BCR ABL1; E1a2; ETV6 RUNX1

Indexed keywords

ALLOPURINOL; ASPARAGINASE MACROGOL; BCR ABL PROTEIN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPIRUBICIN; IMATINIB; IMMUNOGLOBULIN M; METHOTREXATE; METHYLPREDNISOLONE; MICROSOMAL AMINOPEPTIDASE; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; VINCRISTINE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ANTIGEN EXPRESSION; ARTICLE; BCR ABL1 GENE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CASE REPORT; CELL DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; CERVICAL LYMPHADENOPATHY; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; DIARRHEA; ETV6 RUNX1 GENE; FEVER; FLOW CYTOMETRY; FUSION GENE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INDUCTION CHEMOTHERAPY; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; PALLOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; HUMANS; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 84875892974     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2013.01.004     Document Type: Article

References (17)

1. Borowitz M.J., Chan J.K.C. B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 171-175. International Agency for Research on Cancer (IARC), Lyon. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
2. Loh M.L., Samson Y., Motte E., et al. Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet 2000, 122:79-82.
3. Amare Kadam P.S., Raje G.C., Pais A.P., et al. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL. Cancer Genet Cytogenet 2008, 182:27-32.
4. van Dongen J.J., Macintyre E.A., Gabert J.A., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13:1901-1928.
5. Kim A.S., Eastmond D.A., Preston R.J. Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures. Mutat Res 2006, 613:138-160.
6. Fuka G., Kauer M., Kofler R., et al. The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression. PloS One 2011, 6:e26348.
7. Brown P. TEL-AML1 in cord blood: 1% or 0.01%?. Blood 2011, 117:2-4.
8. Mori H., Colman S.M., Xiao Z., et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002, 99:8242-8247.
9. Zuna J., Madzo J., Krejci O., et al. ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood 2011, 117:368-369.
10. De Braekeleer E., Douet-Guilbert N., Morel F., et al. RUNX1 translocations and fusion genes in malignant hemopathies. Future Oncol 2011, 7:77-91.
11. Biernaux C., Loos M., Sels A., et al. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995, 86:3118-3122.
12. Athanasiadou A., Stamatopoulos K., Sakellari I., et al. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia. Bone Marrow Transplant 2004, 34:189-191.
13. Schindler J.W., Van Buren D., Foudi A., et al. TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemia. Cell Stem Cell 2009, 5:43-53.
14. Butt N.M., Rojas J.M., Wang L., et al. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects. Haematologica 2005, 90:1315-1323.
15. Hjalgrim L.L., Madsen H.O., Melbye M., et al. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 2002, 87:994-999.
16. Pais A.P., Amare Kadam P.S., Raje G.C., et al. RUNX1 aberrations in ETV6/ RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL. Pediatr Hematol Oncol 2008, 25:582-597.
17. + acute lymphoblastic leukemia. Blood 2011, 118:5559-5564.